Jilin Province Xidian Pharmaceutical Sci-Tech Development Co.,Ltd (SHE:301130)
China · Delayed Price · Currency is CNY 32.00
+0.46 (1.46%)
Feb 5, 2026, 10:25 AM CST
SHE:301130 Revenue
Jilin Province Xidian Pharmaceutical Sci-Tech Development Co.,Ltd had revenue of 60.63M CNY in the quarter ending September 30, 2025, a decrease of -4.68%. This brings the company's revenue in the last twelve months to 252.77M, up 2.10% year-over-year. In the year 2024, Jilin Province Xidian Pharmaceutical Sci-Tech Development Co.,Ltd had annual revenue of 256.41M with 13.71% growth.
Revenue (ttm)
252.77M
Revenue Growth
+2.10%
P/S Ratio
9.54
Revenue / Employee
789.90K
Employees
320
Market Cap
2.41B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 256.41M | 30.91M | 13.71% |
| Dec 31, 2023 | 225.49M | -29.98M | -11.73% |
| Jan 1, 2023 | 255.47M | -30.19M | -10.57% |
| Jan 1, 2022 | 285.66M | -662.79K | -0.23% |
| Dec 31, 2020 | 286.32M | -38.60M | -11.88% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Anhui Fengyuan Pharmaceutical | 4.15B |
| Hainan Huluwa Pharmaceutical Group | 1.06B |
| Enwei Pharmaceutical | 888.64M |
| ShanXi C&Y Pharmaceutical Group Co.,LTD. | 849.26M |
| Chengdu huasun technology group Inc. , LTD. | 658.28M |
| Ginwa Enterprise (Group) | 550.44M |
| Shaanxi Kanghui Pharmaceutical | 513.23M |
| Zhejiang Shapuaisi Pharmaceutical | 475.19M |